ReP USP - Resultado da busca

Artigo de periodico
Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease (2022)
Lang, Maria Grabriela; Vinagre, Carmen G C; Bonfa, Eloisa Silva Dutra de Oliveira ; Freitas, Fatima R; Pasoto, Sandra Gofinet ; Brito, Tatiane S; Seguro, Luciana P. C; Maranhão, Raul Cavalcante ; Borba, Eduardo F
Source: Lupus. Unidades: FM, FCF
Subjects: COLESTEROL, LIPOPROTEÍNAS, LÚPUS ERITEMATOSO SISTÊMICO, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LANG, Maria Grabriela et al. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease. Lupus, v. 31, n. 6, p. 659-665, 2022Tradução . . Disponível em: https://doi.org/10.1177/09612033221090127. Acesso em: 18 nov. 2024.
APA
Lang, M. G., Vinagre, C. G. C., Bonfa, E. S. D. de O., Freitas, F. R., Pasoto, S. G., Brito, T. S., et al. (2022). Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease. Lupus, 31( 6), 659-665. doi:10.1177/09612033221090127
NLM
Lang MG, Vinagre CGC, Bonfa ESD de O, Freitas FR, Pasoto SG, Brito TS, Seguro LPC, Maranhão RC, Borba EF. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease [Internet]. Lupus. 2022 ; 31( 6): 659-665.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/09612033221090127
Vancouver
Lang MG, Vinagre CGC, Bonfa ESD de O, Freitas FR, Pasoto SG, Brito TS, Seguro LPC, Maranhão RC, Borba EF. Hydroxychloroquine increased cholesterol transfer to high-density lipoprotein in systemic lupus erythematosus: a possible mechanism for the reversal of atherosclerosis in the disease [Internet]. Lupus. 2022 ; 31( 6): 659-665.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1177/09612033221090127
Artigo de periodico
L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals (2021)
Pires, Renier S; Braga, Pedro Gabriel Senger ; Santos, Juliana M. B; Amaral, Jônatas Bussador do ; Amirato, Gislene R; Trettel, Caio dos Santos ; Santos, Carlos A. F. dos; Vaisberg, Mauro ; Nali, Luiz Henrique da Silva ; Vieira, Rodolfo de Paula ; Maranhão, Raul Cavalcante ; Curi, Tania Cristina Phiton ; Barros, Marcelo Paes de ; Bachi, André Luis Lacerda
Source: Experimental Gerontology. Unidades: FCF, FM
Subjects: GLUTAMINA, ANTIOXIDANTES, RADICAIS LIVRES, ARTERIOSCLEROSE, INFLAMAÇÃO, LIPOPROTEÍNAS LDL, COLESTEROL, ESTRESSE OXIDATIVO, DOENÇAS CARDIOVASCULARES, AMINOÁCIDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PIRES, Renier S et al. L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals. Experimental Gerontology, v. 156, p. 1-10 art. 111584, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.exger.2021.111584. Acesso em: 18 nov. 2024.
APA
Pires, R. S., Braga, P. G. S., Santos, J. M. B., Amaral, J. B. do, Amirato, G. R., Trettel, C. dos S., et al. (2021). L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals. Experimental Gerontology, 156, 1-10 art. 111584. doi:10.1016/j.exger.2021.111584
NLM
Pires RS, Braga PGS, Santos JMB, Amaral JB do, Amirato GR, Trettel C dos S, Santos CAF dos, Vaisberg M, Nali LH da S, Vieira R de P, Maranhão RC, Curi TCP, Barros MP de, Bachi ALL. L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals [Internet]. Experimental Gerontology. 2021 ; 156 1-10 art. 111584.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.exger.2021.111584
Vancouver
Pires RS, Braga PGS, Santos JMB, Amaral JB do, Amirato GR, Trettel C dos S, Santos CAF dos, Vaisberg M, Nali LH da S, Vieira R de P, Maranhão RC, Curi TCP, Barros MP de, Bachi ALL. L-glutamine supplementation enhances glutathione peroxidase and paraoxonase-1 activities in HDL of exercising older individuals [Internet]. Experimental Gerontology. 2021 ; 156 1-10 art. 111584.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.exger.2021.111584
Artigo de periodico
TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease (2019)
Duarte, Victor Hugo Rezende ; Miranda, Carolinne Tháısa de Oliveira Fernandes ; Cruz, Marina Sampaio; Araujo, Jessica Nayara Goes de; Duarte, Mychelle Kytchia Rodrigues Nunes; Santos, Ayda Maria Quirino Silva dos; Santos, Isabelle Cristina Clemente dos; Santos, Jéssica Cavalcante dos; Silva, Ananília Medeiros Gomes da; Oliveira, Juliana Marinho de; Paiva, Maria Sanali Moura de Oliveira; Galvão, Marcos Felipe de Oliveira ; Rezende, Adriana Augusto ; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati ; Silbiger, Vivian Nogueira
Source: Scientific Reports. Unidade: FCF
Subjects: EXPRESSÃO GÊNICA, POLIMORFISMO, LEUCÓCITOS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Victor Hugo Rezende et al. TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease. Scientific Reports, v. 9, p. 1-8 art. 7229, 2019Tradução . . Disponível em: https://doi.org/10.1038/s41598-019-43745-y. Acesso em: 18 nov. 2024.
APA
Duarte, V. H. R., Miranda, C. T. de O. F., Cruz, M. S., Araujo, J. N. G. de, Duarte, M. K. R. N., Santos, A. M. Q. S. dos, et al. (2019). TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease. Scientific Reports, 9, 1-8 art. 7229. doi:10.1038/s41598-019-43745-y
NLM
Duarte VHR, Miranda CT de OF, Cruz MS, Araujo JNG de, Duarte MKRN, Santos AMQS dos, Santos ICC dos, Santos JC dos, Silva AMG da, Oliveira JM de, Paiva MSM de O, Galvão MF de O, Rezende AA, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease [Internet]. Scientific Reports. 2019 ; 9 1-8 art. 7229.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-019-43745-y
Vancouver
Duarte VHR, Miranda CT de OF, Cruz MS, Araujo JNG de, Duarte MKRN, Santos AMQS dos, Santos ICC dos, Santos JC dos, Silva AMG da, Oliveira JM de, Paiva MSM de O, Galvão MF de O, Rezende AA, Hirata MH, Hirata RDC, Luchessi AD, Silbiger VN. TREML4 mRNA expression and polymorphisms in blood Leukocytes are associated with atherosclerotic lesion extension in coronary artery disease [Internet]. Scientific Reports. 2019 ; 9 1-8 art. 7229.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1038/s41598-019-43745-y
Artigo de periodico
The effects of diabetes induction on the rat heart: differences in oxidative stress, inflammatory cells, and Fibrosis between subendocardial and interstitial myocardial areas (2017)
Guido, Maria C; Marques, Alyne F; Tavares, Elaine R; Melo, Marcelo Dantas Tavares de; Salemi, Vera M. C; Maranhão, Raul Cavalcante
Source: Oxidative Medicine and Cellular Longevity. Unidade: FCF
Subjects: ESTRESSE OXIDATIVO, INFLAMAÇÃO, CÉLULAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIDO, Maria C et al. The effects of diabetes induction on the rat heart: differences in oxidative stress, inflammatory cells, and Fibrosis between subendocardial and interstitial myocardial areas. Oxidative Medicine and Cellular Longevity, v. 2017, p. 1-11 art. 5343972, 2017Tradução . . Disponível em: https://doi.org/10.1155/2017/5343972. Acesso em: 18 nov. 2024.
APA
Guido, M. C., Marques, A. F., Tavares, E. R., Melo, M. D. T. de, Salemi, V. M. C., & Maranhão, R. C. (2017). The effects of diabetes induction on the rat heart: differences in oxidative stress, inflammatory cells, and Fibrosis between subendocardial and interstitial myocardial areas. Oxidative Medicine and Cellular Longevity, 2017, 1-11 art. 5343972. doi:10.1155/2017/5343972
NLM
Guido MC, Marques AF, Tavares ER, Melo MDT de, Salemi VMC, Maranhão RC. The effects of diabetes induction on the rat heart: differences in oxidative stress, inflammatory cells, and Fibrosis between subendocardial and interstitial myocardial areas [Internet]. Oxidative Medicine and Cellular Longevity. 2017 ; 2017 1-11 art. 5343972.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1155/2017/5343972
Vancouver
Guido MC, Marques AF, Tavares ER, Melo MDT de, Salemi VMC, Maranhão RC. The effects of diabetes induction on the rat heart: differences in oxidative stress, inflammatory cells, and Fibrosis between subendocardial and interstitial myocardial areas [Internet]. Oxidative Medicine and Cellular Longevity. 2017 ; 2017 1-11 art. 5343972.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1155/2017/5343972
Artigo de periodico
The relationship of the oleic acid level and ECHDC3 mRNA expression with the extent of coronary lesion (2016)
Duarte, Mychelle Kytchia Rodrigues Nunes; Araújo, Jéssica Nayara Góes de; Duarte, Victor Hugo Rezende; Oliveira, Katiene Macedo de; Oliveira, Juliana Marinho de; Carioca, Antonio Augusto Ferreira; Bortolin, Raul Hernandes; Rezende, Adriana Augusto de; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Waitzberg, Dan Linetzky; Lima, Severina Carla Vieira Cunha; Luchessi, André Ducati; Silbiger, Vivian Nogueira
Source: Lipids in Health and Disease. Unidades: FCF, FM
Subjects: DOENÇAS CARDIOVASCULARES, ÁCIDOS GRAXOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DUARTE, Mychelle Kytchia Rodrigues Nunes et al. The relationship of the oleic acid level and ECHDC3 mRNA expression with the extent of coronary lesion. Lipids in Health and Disease, v. 15, p. 1-6 art. 144, 2016Tradução . . Disponível em: https://doi.org/10.1186/s12944-016-0312-6. Acesso em: 18 nov. 2024.
APA
Duarte, M. K. R. N., Araújo, J. N. G. de, Duarte, V. H. R., Oliveira, K. M. de, Oliveira, J. M. de, Carioca, A. A. F., et al. (2016). The relationship of the oleic acid level and ECHDC3 mRNA expression with the extent of coronary lesion. Lipids in Health and Disease, 15, 1-6 art. 144. doi:10.1186/s12944-016-0312-6
NLM
Duarte MKRN, Araújo JNG de, Duarte VHR, Oliveira KM de, Oliveira JM de, Carioca AAF, Bortolin RH, Rezende AA de, Hirata MH, Hirata RDC, Waitzberg DL, Lima SCVC, Luchessi AD, Silbiger VN. The relationship of the oleic acid level and ECHDC3 mRNA expression with the extent of coronary lesion [Internet]. Lipids in Health and Disease. 2016 ; 15 1-6 art. 144.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12944-016-0312-6
Vancouver
Duarte MKRN, Araújo JNG de, Duarte VHR, Oliveira KM de, Oliveira JM de, Carioca AAF, Bortolin RH, Rezende AA de, Hirata MH, Hirata RDC, Waitzberg DL, Lima SCVC, Luchessi AD, Silbiger VN. The relationship of the oleic acid level and ECHDC3 mRNA expression with the extent of coronary lesion [Internet]. Lipids in Health and Disease. 2016 ; 15 1-6 art. 144.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12944-016-0312-6
Artigo de periodico
New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice (2016)
Silva, Jacqueline Cavalcante; César, Fernanda Andrade de; Oliveira, Edson Mendes de; Turato, Walter Miguel; Tripodi, Gustavo L; Castilho, Gabriela; Lima, Adriana Machado; Las Heras, Beatriz de; Boscá, Lisardo; Rabello, Marcelo M; Hernandes, Marcelo Zaldini; Pitta, Marina G. R; Pitta, Ivan Rocha; Passarelli, Marisa; Rudnicki, Martina; Abdalla, Dulcinéia Saes Parra
Source: Pharmacological Research. Unidades: FCF, FM
Subjects: ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES, EXPRESSÃO GÊNICA, ADIPONECTINA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Jacqueline Cavalcante et al. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice. Pharmacological Research, v. 104, p. 49-60, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.phrs.2015.12.010. Acesso em: 18 nov. 2024.
APA
Silva, J. C., César, F. A. de, Oliveira, E. M. de, Turato, W. M., Tripodi, G. L., Castilho, G., et al. (2016). New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice. Pharmacological Research, 104, 49-60. doi:10.1016/j.phrs.2015.12.010
NLM
Silva JC, César FA de, Oliveira EM de, Turato WM, Tripodi GL, Castilho G, Lima AM, Las Heras B de, Boscá L, Rabello MM, Hernandes MZ, Pitta MGR, Pitta IR, Passarelli M, Rudnicki M, Abdalla DSP. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice [Internet]. Pharmacological Research. 2016 ; 104 49-60.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.phrs.2015.12.010
Vancouver
Silva JC, César FA de, Oliveira EM de, Turato WM, Tripodi GL, Castilho G, Lima AM, Las Heras B de, Boscá L, Rabello MM, Hernandes MZ, Pitta MGR, Pitta IR, Passarelli M, Rudnicki M, Abdalla DSP. New PPAR partial agonist improves obesity-induced metabolic alterations and atherosclerosis in LDLr−/− mice [Internet]. Pharmacological Research. 2016 ; 104 49-60.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.phrs.2015.12.010
Artigo de periodico
Troponin in diabetic patients with and without chronic coronary artery disease (2015)
Segre, Carlos Alexandre Wainrober; Hueb, Whady Armindo; Garcia, Rosa Maria Rahmi; Rezende, Paulo Cury; Favarato, Desiderio; Strunz, Célia Maria Cassaro; Sprandel, Marília da Costa Oliveira; Roggério, Alessandra; Carvalho, Ana Luiza de Oliveira; Maranhão, Raul Cavalcante ; Ramires, José Antônio Franchini; Kalil Filho, Roberto
Source: BMC Cardiovascular Disorders. Unidades: FM, FCF
Subjects: TROPONINA, BIOMARCADORES, DIABETES MELLITUS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEGRE, Carlos Alexandre Wainrober et al. Troponin in diabetic patients with and without chronic coronary artery disease. BMC Cardiovascular Disorders, v. 15, p. 1-6 art. 72, 2015Tradução . . Disponível em: https://doi.org/10.1186/s12872-015-0051-z. Acesso em: 18 nov. 2024.
APA
Segre, C. A. W., Hueb, W. A., Garcia, R. M. R., Rezende, P. C., Favarato, D., Strunz, C. M. C., et al. (2015). Troponin in diabetic patients with and without chronic coronary artery disease. BMC Cardiovascular Disorders, 15, 1-6 art. 72. doi:10.1186/s12872-015-0051-z
NLM
Segre CAW, Hueb WA, Garcia RMR, Rezende PC, Favarato D, Strunz CMC, Sprandel M da CO, Roggério A, Carvalho AL de O, Maranhão RC, Ramires JAF, Kalil Filho R. Troponin in diabetic patients with and without chronic coronary artery disease [Internet]. BMC Cardiovascular Disorders. 2015 ; 15 1-6 art. 72.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12872-015-0051-z
Vancouver
Segre CAW, Hueb WA, Garcia RMR, Rezende PC, Favarato D, Strunz CMC, Sprandel M da CO, Roggério A, Carvalho AL de O, Maranhão RC, Ramires JAF, Kalil Filho R. Troponin in diabetic patients with and without chronic coronary artery disease [Internet]. BMC Cardiovascular Disorders. 2015 ; 15 1-6 art. 72.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1186/s12872-015-0051-z
Artigo de periodico
Advances in non-invasive drug delivery for atherosclerotic heart disease (2015)
Maranhão, Raul Cavalcante ; Tavares, Elaine Rufo
Source: Expert Opinion on Drug Delivery. Unidade: FCF
Subjects: DOENÇAS CARDIOVASCULARES, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARANHÃO, Raul Cavalcante e TAVARES, Elaine Rufo. Advances in non-invasive drug delivery for atherosclerotic heart disease. Expert Opinion on Drug Delivery, v. 12, n. 7, p. 1135-1147, 2015Tradução . . Disponível em: https://doi.org/10.1517/17425247.2015.999663. Acesso em: 18 nov. 2024.
APA
Maranhão, R. C., & Tavares, E. R. (2015). Advances in non-invasive drug delivery for atherosclerotic heart disease. Expert Opinion on Drug Delivery, 12( 7), 1135-1147. doi:10.1517/17425247.2015.999663
NLM
Maranhão RC, Tavares ER. Advances in non-invasive drug delivery for atherosclerotic heart disease [Internet]. Expert Opinion on Drug Delivery. 2015 ; 12( 7): 1135-1147.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1517/17425247.2015.999663
Vancouver
Maranhão RC, Tavares ER. Advances in non-invasive drug delivery for atherosclerotic heart disease [Internet]. Expert Opinion on Drug Delivery. 2015 ; 12( 7): 1135-1147.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1517/17425247.2015.999663
Artigo de periodico
Metabolism of triglyceride-rich lipoproteins and transfer of lipids to high-density lipoproteins (HDL) in vegan and omnivore subjects (2013)
Vinagre, Juliana Christiano de Matos; Vinagre, Carmen Guilherme Christiano de Matos; Pozzi, Fernanda Santos; Slywitch, E; Maranhão, Raul Cavalcante
Source: Nutrition, Metabolism & Cardiovascular Diseases. Unidade: FCF
Subjects: DOENÇAS CARDIOVASCULARES, NANOPARTÍCULAS, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VINAGRE, Juliana Christiano de Matos et al. Metabolism of triglyceride-rich lipoproteins and transfer of lipids to high-density lipoproteins (HDL) in vegan and omnivore subjects. Nutrition, Metabolism & Cardiovascular Diseases, v. 23, n. 1, p. 61-67, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.numecd.2011.02.011. Acesso em: 18 nov. 2024.
APA
Vinagre, J. C. de M., Vinagre, C. G. C. de M., Pozzi, F. S., Slywitch, E., & Maranhão, R. C. (2013). Metabolism of triglyceride-rich lipoproteins and transfer of lipids to high-density lipoproteins (HDL) in vegan and omnivore subjects. Nutrition, Metabolism & Cardiovascular Diseases, 23( 1), 61-67. doi:10.1016/j.numecd.2011.02.011
NLM
Vinagre JC de M, Vinagre CGC de M, Pozzi FS, Slywitch E, Maranhão RC. Metabolism of triglyceride-rich lipoproteins and transfer of lipids to high-density lipoproteins (HDL) in vegan and omnivore subjects [Internet]. Nutrition, Metabolism & Cardiovascular Diseases. 2013 ; 23( 1): 61-67.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.numecd.2011.02.011
Vancouver
Vinagre JC de M, Vinagre CGC de M, Pozzi FS, Slywitch E, Maranhão RC. Metabolism of triglyceride-rich lipoproteins and transfer of lipids to high-density lipoproteins (HDL) in vegan and omnivore subjects [Internet]. Nutrition, Metabolism & Cardiovascular Diseases. 2013 ; 23( 1): 61-67.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.numecd.2011.02.011
Trabalho de evento-resumo periodico
Patients with precocious coronary artery disease show decreased transfer of free cholesterol to high-density-lipoprotein (HDL) (2010)
Freitas, F. R. S; Strunz, Célia Cassaro; Mansur, Alfredo Jose; Mansur, Antonio de Padua; Maranhão, Raul Cavalcante
Source: European Heart Journal. Conference titles: ESC Congress. Unidades: FM, FCF
Subjects: LIPOPROTEÍNAS, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FREITAS, F. R. S et al. Patients with precocious coronary artery disease show decreased transfer of free cholesterol to high-density-lipoprotein (HDL). European Heart Journal. oxford: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2010
APA
Freitas, F. R. S., Strunz, C. C., Mansur, A. J., Mansur, A. de P., & Maranhão, R. C. (2010). Patients with precocious coronary artery disease show decreased transfer of free cholesterol to high-density-lipoprotein (HDL). European Heart Journal. oxford: Faculdade de Medicina, Universidade de São Paulo.
NLM
Freitas FRS, Strunz CC, Mansur AJ, Mansur A de P, Maranhão RC. Patients with precocious coronary artery disease show decreased transfer of free cholesterol to high-density-lipoprotein (HDL). European Heart Journal. 2010 ; 31 102 res. P706.[citado 2024 nov. 18 ]
Vancouver
Freitas FRS, Strunz CC, Mansur AJ, Mansur A de P, Maranhão RC. Patients with precocious coronary artery disease show decreased transfer of free cholesterol to high-density-lipoprotein (HDL). European Heart Journal. 2010 ; 31 102 res. P706.[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
Use of cholesterol-rich nanoemulsions as vehicles for alpha-tocopherol reduces atherosclerotic lesions in the rabbit (2010)
Ficker, Elisabeth Salvatori; Tavares, Elaine Rufo; Souza, A. M. B; Bonaco, A. L; Morikawa, Aleksandra Tiemi; Pereira, M. D; Maranhão, Raul Cavalcante
Source: European Heart Journal. Conference titles: ESC Congress. Unidade: FCF
Subjects: ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FICKER, Elisabeth Salvatori et al. Use of cholesterol-rich nanoemulsions as vehicles for alpha-tocopherol reduces atherosclerotic lesions in the rabbit. European Heart Journal. oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2010
APA
Ficker, E. S., Tavares, E. R., Souza, A. M. B., Bonaco, A. L., Morikawa, A. T., Pereira, M. D., & Maranhão, R. C. (2010). Use of cholesterol-rich nanoemulsions as vehicles for alpha-tocopherol reduces atherosclerotic lesions in the rabbit. European Heart Journal. oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Ficker ES, Tavares ER, Souza AMB, Bonaco AL, Morikawa AT, Pereira MD, Maranhão RC. Use of cholesterol-rich nanoemulsions as vehicles for alpha-tocopherol reduces atherosclerotic lesions in the rabbit. European Heart Journal. 2010 ; 31 1025 res. P5564.[citado 2024 nov. 18 ]
Vancouver
Ficker ES, Tavares ER, Souza AMB, Bonaco AL, Morikawa AT, Pereira MD, Maranhão RC. Use of cholesterol-rich nanoemulsions as vehicles for alpha-tocopherol reduces atherosclerotic lesions in the rabbit. European Heart Journal. 2010 ; 31 1025 res. P5564.[citado 2024 nov. 18 ]
Trabalho de evento-resumo periodico
Combined chemotherapy of methotrexate and etoposide, both associated with lipidic nanoemulsions (LDE), promotes atherosclerosis regression in the rabbit (2010)
Leite Junior, Antonio Carlos; Tavares, Elaine Rufo; Bulgarelli, Adriana; Maranhão, Raul Cavalcante
Source: European Heart Journal. Conference titles: ESC Congress. Unidade: FCF
Subjects: ARTERIOSCLEROSE, DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEITE JUNIOR, Antonio Carlos et al. Combined chemotherapy of methotrexate and etoposide, both associated with lipidic nanoemulsions (LDE), promotes atherosclerosis regression in the rabbit. European Heart Journal. oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 18 nov. 2024. , 2010
APA
Leite Junior, A. C., Tavares, E. R., Bulgarelli, A., & Maranhão, R. C. (2010). Combined chemotherapy of methotrexate and etoposide, both associated with lipidic nanoemulsions (LDE), promotes atherosclerosis regression in the rabbit. European Heart Journal. oxford: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Leite Junior AC, Tavares ER, Bulgarelli A, Maranhão RC. Combined chemotherapy of methotrexate and etoposide, both associated with lipidic nanoemulsions (LDE), promotes atherosclerosis regression in the rabbit. European Heart Journal. 2010 ; 31 1024 res. P5559.[citado 2024 nov. 18 ]
Vancouver
Leite Junior AC, Tavares ER, Bulgarelli A, Maranhão RC. Combined chemotherapy of methotrexate and etoposide, both associated with lipidic nanoemulsions (LDE), promotes atherosclerosis regression in the rabbit. European Heart Journal. 2010 ; 31 1024 res. P5559.[citado 2024 nov. 18 ]
Artigo de periodico
Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin (2009)
Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Clinica Lipidology. Unidade: FCF
Subjects: DOENÇAS CARDIOVASCULARES, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, GENOMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HIRATA, Rosario Dominguez Crespo e HIRATA, Mario Hiroyuki. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, v. 4, n. 4, p. 419-423, 2009Tradução . . Disponível em: https://doi.org/10.2217/clp.09.32. Acesso em: 18 nov. 2024.
APA
Hirata, R. D. C., & Hirata, M. H. (2009). Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin. Clinica Lipidology, 4( 4), 419-423. doi:10.2217/clp.09.32
NLM
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/clp.09.32
Vancouver
Hirata RDC, Hirata MH. Genome-wide and candidate genes approach for pharmacogenomics of atorvastatin [Internet]. Clinica Lipidology. 2009 ; 4( 4): 419-423.[citado 2024 nov. 18 ] Available from: https://doi.org/10.2217/clp.09.32

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Date published

Subjects

Source title

Funding Agencies

Indexado em

Non normalized affiliation